Top Markets
Coin of the day
AmCad BioMed Corporation AmCad BioMed Corporation

AmCad BioMed Corporation

4188
Rang in Aktien #29620
AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD)... AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD) software devices primarily in Taiwan. It offers products for early detection and diagnosis of various diseases. The company's products include AmCAD-UT Detection, a CAD device for ultrasound images of thyroid nodules; and AmCAD-UO for detection of obstructive sleep apnea on awake patients. It also developing AmCAD-US, a software device for visualizing and quantifying statistical distributions of backscattered signals echoed by tissue compositions in the body from FDA-cleared ultrasound systems; and AmCAD-UB, an AI Solution for Breast Lesion Detection. The company was incorporated in 2008 and is based in Taipei City, Taiwan.
Aktienkurs
$0.32117018
Marktkapitalisierung
$20.34M
Veränderung (1 Tag)
-0.98%
Veränderung (1 Jahr)
-34.41%
Land
TW
Handel AmCad BioMed Corporation (4188)

Kategorie

Aktien-Split-Historie für AmCad BioMed Corporation (4188)
Die Aktie AmCad BioMed Corporation (Symbol: 4188) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 19, 2026 statt.
Eine 4188-Aktie, die vor dem Aug 19, 2026 gekauft wurde, entspricht heute 0 4188-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
4 x600
DE
0 -
CA
1 x4
US
0 -
US
1 x4
US